

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.78935360 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.78935360 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.07593376 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.03804033 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.03804033 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71090385 |
| 7 | leukocyte aggregation (GO:0070486) | 4.35403127 |
| 8 | hemidesmosome assembly (GO:0031581) | 4.24037525 |
| 9 | interferon-gamma secretion (GO:0072643) | 4.20433066 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.87053479 |
| 11 | T cell migration (GO:0072678) | 3.75592434 |
| 12 | NIK/NF-kappaB signaling (GO:0038061) | 3.75220951 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.74866292 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.72255850 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.72255850 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.72255850 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.72255850 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.72255850 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.72255850 |
| 20 | tolerance induction (GO:0002507) | 3.63665706 |
| 21 | detection of bacterium (GO:0016045) | 3.60562061 |
| 22 | detection of other organism (GO:0098543) | 3.56607471 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.49920278 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 3.46174774 |
| 25 | response to interleukin-15 (GO:0070672) | 3.40513949 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.39699703 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.38023079 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34593353 |
| 29 | regulation of cholesterol homeostasis (GO:2000188) | 3.31693806 |
| 30 | desmosome organization (GO:0002934) | 3.31423136 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.31131958 |
| 32 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.30280978 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.30104452 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.30104452 |
| 35 | response to type I interferon (GO:0034340) | 3.27976641 |
| 36 | positive T cell selection (GO:0043368) | 3.27286098 |
| 37 | response to peptidoglycan (GO:0032494) | 3.26244428 |
| 38 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25076386 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.23681797 |
| 40 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.22876544 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18185272 |
| 42 | thymic T cell selection (GO:0045061) | 3.17981282 |
| 43 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.14241125 |
| 44 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.14241125 |
| 45 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.11269908 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.11214060 |
| 47 | skin morphogenesis (GO:0043589) | 3.11095640 |
| 48 | positive thymic T cell selection (GO:0045059) | 3.08890607 |
| 49 | epithelial cell-cell adhesion (GO:0090136) | 3.08502434 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.04396857 |
| 51 | Golgi transport vesicle coating (GO:0048200) | 3.03443640 |
| 52 | COPI coating of Golgi vesicle (GO:0048205) | 3.03443640 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 3.03305006 |
| 54 | regulation of B cell differentiation (GO:0045577) | 3.01727027 |
| 55 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.01414054 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.01219185 |
| 57 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00753755 |
| 58 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00438053 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.99895068 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99442592 |
| 61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98844811 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93480982 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91826296 |
| 64 | germinal center formation (GO:0002467) | 2.88931763 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 2.88263993 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87491802 |
| 67 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.85877951 |
| 68 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.84818473 |
| 69 | neutrophil activation (GO:0042119) | 2.83365139 |
| 70 | response to laminar fluid shear stress (GO:0034616) | 2.82983107 |
| 71 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.81133607 |
| 72 | cell-substrate junction assembly (GO:0007044) | 2.80865671 |
| 73 | detection of external biotic stimulus (GO:0098581) | 2.76828046 |
| 74 | granulocyte activation (GO:0036230) | 2.76651677 |
| 75 | positive regulation of interleukin-2 production (GO:0032743) | 2.75532993 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 2.75329637 |
| 77 | regulation of hippo signaling (GO:0035330) | 2.74781979 |
| 78 | regulation of translational termination (GO:0006449) | 2.74667865 |
| 79 | apoptotic cell clearance (GO:0043277) | 2.74595898 |
| 80 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.74095131 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72178917 |
| 82 | endothelial tube morphogenesis (GO:0061154) | 2.72077004 |
| 83 | morphogenesis of an endothelium (GO:0003159) | 2.72077004 |
| 84 | negative regulation of interleukin-6 production (GO:0032715) | 2.71866045 |
| 85 | regulation of water loss via skin (GO:0033561) | 2.71097975 |
| 86 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.70948550 |
| 87 | negative regulation of stress fiber assembly (GO:0051497) | 2.70291341 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70235533 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.70019790 |
| 90 | regulation of defense response to virus by virus (GO:0050690) | 2.69338552 |
| 91 | lymphocyte migration (GO:0072676) | 2.69195452 |
| 92 | negative thymic T cell selection (GO:0045060) | 2.68912618 |
| 93 | defense response to protozoan (GO:0042832) | 2.68776428 |
| 94 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68550250 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68550250 |
| 96 | T cell receptor signaling pathway (GO:0050852) | 2.67555234 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.67011490 |
| 98 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.63537108 |
| 99 | hair cycle (GO:0042633) | 2.62438962 |
| 100 | molting cycle (GO:0042303) | 2.62438962 |
| 101 | negative regulation of type 2 immune response (GO:0002829) | 2.61630426 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.61435951 |
| 103 | T cell apoptotic process (GO:0070231) | 2.61105146 |
| 104 | respiratory burst (GO:0045730) | 2.60452538 |
| 105 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.60135558 |
| 106 | actin nucleation (GO:0045010) | 2.59491314 |
| 107 | mannose metabolic process (GO:0006013) | 2.59475418 |
| 108 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.59385701 |
| 109 | T-helper cell differentiation (GO:0042093) | 2.59385701 |
| 110 | cellular extravasation (GO:0045123) | 2.59348827 |
| 111 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.59307196 |
| 112 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.59243866 |
| 113 | response to protozoan (GO:0001562) | 2.59072339 |
| 114 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.59061137 |
| 115 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.58736650 |
| 116 | regulation of cell killing (GO:0031341) | 2.58669944 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 2.58010879 |
| 118 | negative T cell selection (GO:0043383) | 2.57579353 |
| 119 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.54147776 |
| 120 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.51609340 |
| 121 | maternal placenta development (GO:0001893) | 2.51368381 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50765529 |
| 123 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.49722769 |
| 124 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.47578093 |
| 125 | positive regulation of nuclease activity (GO:0032075) | 2.47385897 |
| 126 | T cell selection (GO:0045058) | 2.47070998 |
| 127 | natural killer cell differentiation (GO:0001779) | 2.46878913 |
| 128 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.46737046 |
| 129 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.44509454 |
| 130 | apoptotic process involved in morphogenesis (GO:0060561) | 2.43363710 |
| 131 | type B pancreatic cell proliferation (GO:0044342) | 2.38980831 |
| 132 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.37700728 |
| 133 | positive regulation of lamellipodium assembly (GO:0010592) | 2.35554070 |
| 134 | protein retention in ER lumen (GO:0006621) | 2.34864936 |
| 135 | regulation of response to interferon-gamma (GO:0060330) | 2.33916823 |
| 136 | growth hormone receptor signaling pathway (GO:0060396) | 2.33223093 |
| 137 | trophectodermal cell differentiation (GO:0001829) | 2.32240810 |
| 138 | endodermal cell differentiation (GO:0035987) | 2.31881427 |
| 139 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.31011165 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.30096190 |
| 141 | cysteine metabolic process (GO:0006534) | 2.29607100 |
| 142 | establishment of skin barrier (GO:0061436) | 2.29354080 |
| 143 | 4-hydroxyproline metabolic process (GO:0019471) | 2.28799000 |
| 144 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.27967141 |
| 145 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.27861477 |
| 146 | regulation of natural killer cell differentiation (GO:0032823) | 2.26774636 |
| 147 | valine metabolic process (GO:0006573) | 2.26244110 |
| 148 | regulation of gene silencing by RNA (GO:0060966) | 2.25979445 |
| 149 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.25979445 |
| 150 | regulation of gene silencing by miRNA (GO:0060964) | 2.25979445 |
| 151 | cellular response to nutrient (GO:0031670) | 2.25098384 |
| 152 | platelet aggregation (GO:0070527) | 2.24871724 |
| 153 | blood vessel endothelial cell migration (GO:0043534) | 2.23942735 |
| 154 | positive regulation of p38MAPK cascade (GO:1900745) | 2.23885707 |
| 155 | regulation of nuclease activity (GO:0032069) | 2.23293721 |
| 156 | basement membrane organization (GO:0071711) | 2.23254757 |
| 157 | folic acid metabolic process (GO:0046655) | 2.23219534 |
| 158 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.23121409 |
| 159 | response to muramyl dipeptide (GO:0032495) | 2.20281652 |
| 160 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.20166759 |
| 161 | regulation of early endosome to late endosome transport (GO:2000641) | 2.20049751 |
| 162 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.18477097 |
| 163 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.18301360 |
| 164 | positive regulation of histone deacetylation (GO:0031065) | 2.17993131 |
| 165 | lymphocyte apoptotic process (GO:0070227) | 2.17485052 |
| 166 | nodal signaling pathway (GO:0038092) | 2.16430482 |
| 167 | negative regulation of lipid transport (GO:0032369) | 2.16337017 |
| 168 | regulation of tight junction assembly (GO:2000810) | 2.15902748 |
| 169 | low-density lipoprotein particle clearance (GO:0034383) | 2.15510050 |
| 170 | formation of translation preinitiation complex (GO:0001731) | 2.15450131 |
| 171 | cell adhesion mediated by integrin (GO:0033627) | 2.15082954 |
| 172 | barbed-end actin filament capping (GO:0051016) | 2.14807970 |
| 173 | tricarboxylic acid metabolic process (GO:0072350) | 2.12135513 |
| 174 | proline biosynthetic process (GO:0006561) | 2.11131785 |
| 175 | negative regulation of sterol transport (GO:0032372) | 2.10255974 |
| 176 | negative regulation of cholesterol transport (GO:0032375) | 2.10255974 |
| 177 | endothelial cell chemotaxis (GO:0035767) | 2.09354407 |
| 178 | regulation of translational fidelity (GO:0006450) | 2.08425696 |
| 179 | positive regulation of lamellipodium organization (GO:1902745) | 2.07812577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.58226725 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.28204245 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.99247114 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.62180485 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.54790584 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.49127920 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40895671 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.37671536 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.33222313 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29024600 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25067673 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.18623918 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17797239 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06663654 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00570466 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.99583887 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99505109 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99365640 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94131900 |
| 20 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.91361086 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89627550 |
| 22 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89223493 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.87579222 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83726222 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79656913 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77727673 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76616060 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.76548199 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74801296 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73696723 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72898305 |
| 32 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70999061 |
| 33 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67815429 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67727073 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66088809 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64473255 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.64232057 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63598835 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63519978 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.62064753 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60606974 |
| 42 | ATF3_27146783_Chip-Seq_COLON_Human | 1.59825049 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59732483 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59366885 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57938922 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55875031 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49869895 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49569727 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49037962 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49019363 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44933006 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44552526 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44387448 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43850175 |
| 55 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.43593511 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41237666 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40984305 |
| 58 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40949885 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38738741 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37004408 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35626070 |
| 62 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35490018 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35427157 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35425091 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34527157 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33852463 |
| 67 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.33684826 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.33162636 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31661564 |
| 70 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30399252 |
| 71 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29192758 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28445295 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27535316 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27253836 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25817376 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25364975 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24605343 |
| 78 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.23831393 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22112617 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21731551 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20452271 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20167110 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20100295 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19977087 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18957097 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18908877 |
| 87 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.17949146 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17574514 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16346192 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 1.15237618 |
| 91 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14809925 |
| 92 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.14645163 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14295538 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13137314 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12600288 |
| 96 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12368216 |
| 97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12122319 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11187188 |
| 99 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10978788 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10855555 |
| 101 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.10682080 |
| 102 | MYB_26560356_Chip-Seq_TH1_Human | 1.10665901 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09171071 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09155734 |
| 105 | * MAF_26560356_Chip-Seq_TH2_Human | 1.08419964 |
| 106 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08151168 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07128426 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06968302 |
| 109 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.06435708 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05912257 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05423424 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05003215 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04304293 |
| 114 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03456431 |
| 115 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02997664 |
| 116 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02499462 |
| 117 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02322342 |
| 118 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01420486 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01355758 |
| 120 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00974091 |
| 121 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.00968728 |
| 122 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00945491 |
| 123 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00924495 |
| 124 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00075173 |
| 125 | P68_20966046_ChIP-Seq_HELA_Human | 0.99920385 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99665220 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99206563 |
| 128 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98722108 |
| 129 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97899588 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97891477 |
| 131 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97793023 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97790044 |
| 133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97553013 |
| 134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96586951 |
| 135 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.96397230 |
| 136 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95348448 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95332532 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95251362 |
| 139 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95233396 |
| 140 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94559895 |
| 141 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94332595 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93949192 |
| 143 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93798836 |
| 144 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.93647760 |
| 145 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93232202 |
| 146 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93232202 |
| 147 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93204780 |
| 148 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.92869940 |
| 149 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92274432 |
| 150 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92209543 |
| 151 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92011928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 3.67164566 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.66133984 |
| 3 | MP0003724_increased_susceptibility_to | 3.55808359 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.06277145 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.71641124 |
| 6 | MP0009785_altered_susceptibility_to | 2.68267695 |
| 7 | MP0003566_abnormal_cell_adhesion | 2.62784286 |
| 8 | MP0002419_abnormal_innate_immunity | 2.58923535 |
| 9 | MP0009840_abnormal_foam_cell | 2.55911888 |
| 10 | MP0005275_abnormal_skin_tensile | 2.48713339 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.35634590 |
| 12 | MP0000685_abnormal_immune_system | 2.30989951 |
| 13 | MP0002796_impaired_skin_barrier | 2.19744141 |
| 14 | MP0004947_skin_inflammation | 2.10709028 |
| 15 | MP0005023_abnormal_wound_healing | 1.94131727 |
| 16 | MP0003763_abnormal_thymus_physiology | 1.88502390 |
| 17 | MP0005076_abnormal_cell_differentiation | 1.84024520 |
| 18 | MP0003436_decreased_susceptibility_to | 1.80916427 |
| 19 | MP0003453_abnormal_keratinocyte_physiol | 1.80381197 |
| 20 | MP0008260_abnormal_autophagy | 1.79284593 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.78967569 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.77495246 |
| 23 | MP0004381_abnormal_hair_follicle | 1.77059684 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.69414379 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.64225677 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.59617362 |
| 27 | MP0005360_urolithiasis | 1.59545877 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.57501681 |
| 29 | MP0001849_ear_inflammation | 1.56828106 |
| 30 | MP0003866_abnormal_defecation | 1.52439572 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.48717604 |
| 32 | MP0005501_abnormal_skin_physiology | 1.48442714 |
| 33 | MP0002060_abnormal_skin_morphology | 1.47513601 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.47074226 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.45378269 |
| 36 | MP0005451_abnormal_body_composition | 1.43860094 |
| 37 | MP0001216_abnormal_epidermal_layer | 1.42434428 |
| 38 | MP0002429_abnormal_blood_cell | 1.42117825 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.42020212 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.36694698 |
| 41 | MP0008469_abnormal_protein_level | 1.36415360 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.33299539 |
| 43 | MP0003303_peritoneal_inflammation | 1.33167044 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.32717613 |
| 45 | MP0001853_heart_inflammation | 1.32649664 |
| 46 | MP0009764_decreased_sensitivity_to | 1.32489752 |
| 47 | MP0009278_abnormal_bone_marrow | 1.31898021 |
| 48 | MP0003828_pulmonary_edema | 1.31313863 |
| 49 | MP0000858_altered_metastatic_potential | 1.30142410 |
| 50 | MP0005310_abnormal_salivary_gland | 1.28305618 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.28258078 |
| 52 | MP0003075_altered_response_to | 1.27322669 |
| 53 | MP0001243_abnormal_dermal_layer | 1.25814657 |
| 54 | MP0001958_emphysema | 1.23061416 |
| 55 | MP0004510_myositis | 1.14706174 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.12690006 |
| 57 | MP0003091_abnormal_cell_migration | 1.11903741 |
| 58 | MP0001873_stomach_inflammation | 1.11059885 |
| 59 | MP0001790_abnormal_immune_system | 1.10448776 |
| 60 | MP0005387_immune_system_phenotype | 1.10448776 |
| 61 | MP0002006_tumorigenesis | 1.09846565 |
| 62 | MP0001851_eye_inflammation | 1.09404028 |
| 63 | MP0000377_abnormal_hair_follicle | 1.09183120 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.09147757 |
| 65 | MP0001800_abnormal_humoral_immune | 1.06781082 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.04714328 |
| 67 | MP0010307_abnormal_tumor_latency | 1.03774523 |
| 68 | MP0003693_abnormal_embryo_hatching | 1.03359094 |
| 69 | MP0000604_amyloidosis | 1.03046940 |
| 70 | MP0005390_skeleton_phenotype | 1.02643370 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.00286812 |
| 72 | MP0000609_abnormal_liver_physiology | 0.99644893 |
| 73 | MP0002452_abnormal_antigen_presenting | 0.98754311 |
| 74 | MP0002405_respiratory_system_inflammati | 0.98011907 |
| 75 | MP0005000_abnormal_immune_tolerance | 0.97326475 |
| 76 | MP0009643_abnormal_urine_homeostasis | 0.96538904 |
| 77 | MP0009384_cardiac_valve_regurgitation | 0.96155948 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.95311604 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.95289176 |
| 80 | MP0003279_aneurysm | 0.95247253 |
| 81 | MP0002098_abnormal_vibrissa_morphology | 0.95086758 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.94851973 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.94366680 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.94366680 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.94211825 |
| 86 | MP0009931_abnormal_skin_appearance | 0.94165678 |
| 87 | MP0005166_decreased_susceptibility_to | 0.93783799 |
| 88 | MP0002722_abnormal_immune_system | 0.92994978 |
| 89 | MP0001533_abnormal_skeleton_physiology | 0.92274197 |
| 90 | MP0002398_abnormal_bone_marrow | 0.92087471 |
| 91 | MP0005671_abnormal_response_to | 0.91679669 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.91469919 |
| 93 | MP0001819_abnormal_immune_cell | 0.89886440 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.89739560 |
| 95 | MP0002420_abnormal_adaptive_immunity | 0.89198524 |
| 96 | MP0002723_abnormal_immune_serum | 0.89184618 |
| 97 | MP0003878_abnormal_ear_physiology | 0.88876842 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.88876842 |
| 99 | MP0005365_abnormal_bile_salt | 0.88801146 |
| 100 | MP0000579_abnormal_nail_morphology | 0.88448263 |
| 101 | MP0003941_abnormal_skin_development | 0.87516488 |
| 102 | MP0003448_altered_tumor_morphology | 0.87487230 |
| 103 | MP0000343_altered_response_to | 0.86805072 |
| 104 | MP0006054_spinal_hemorrhage | 0.86553638 |
| 105 | MP0006082_CNS_inflammation | 0.86347101 |
| 106 | MP0008007_abnormal_cellular_replicative | 0.85816210 |
| 107 | MP0008004_abnormal_stomach_pH | 0.85383406 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.85229537 |
| 109 | MP0003252_abnormal_bile_duct | 0.85140408 |
| 110 | MP0000689_abnormal_spleen_morphology | 0.84860712 |
| 111 | MP0002933_joint_inflammation | 0.84581242 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.84391320 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.82367458 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.82247291 |
| 115 | MP0005025_abnormal_response_to | 0.82090391 |
| 116 | MP0003045_fibrosis | 0.82061078 |
| 117 | MP0004957_abnormal_blastocyst_morpholog | 0.81717153 |
| 118 | MP0001542_abnormal_bone_strength | 0.81702777 |
| 119 | MP0004883_abnormal_blood_vessel | 0.81560596 |
| 120 | MP0000716_abnormal_immune_system | 0.81407716 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.81273578 |
| 122 | MP0002132_abnormal_respiratory_system | 0.81153398 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.80850993 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.79865961 |
| 125 | MP0001191_abnormal_skin_condition | 0.79489097 |
| 126 | MP0009763_increased_sensitivity_to | 0.78921842 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.77914198 |
| 128 | MP0001663_abnormal_digestive_system | 0.77858934 |
| 129 | MP0009053_abnormal_anal_canal | 0.77807217 |
| 130 | MP0003795_abnormal_bone_structure | 0.77443111 |
| 131 | MP0000467_abnormal_esophagus_morphology | 0.76628687 |
| 132 | MP0000249_abnormal_blood_vessel | 0.76472649 |
| 133 | MP0005085_abnormal_gallbladder_physiolo | 0.76437257 |
| 134 | MP0000733_abnormal_muscle_development | 0.75972167 |
| 135 | MP0010030_abnormal_orbit_morphology | 0.75621956 |
| 136 | MP0000350_abnormal_cell_proliferation | 0.75594290 |
| 137 | MP0005164_abnormal_response_to | 0.72257123 |
| 138 | MP0004858_abnormal_nervous_system | 0.66218837 |
| 139 | MP0003690_abnormal_glial_cell | 0.63992837 |
| 140 | MP0003329_amyloid_beta_deposits | 0.63967690 |
| 141 | MP0000490_abnormal_crypts_of | 0.63872085 |
| 142 | MP0008874_decreased_physiological_sensi | 0.62960058 |
| 143 | MP0000767_abnormal_smooth_muscle | 0.60765284 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.59558814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.63435543 |
| 2 | Myositis (HP:0100614) | 4.56207546 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.51536166 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.37243540 |
| 5 | Orchitis (HP:0100796) | 3.94127608 |
| 6 | Stomatitis (HP:0010280) | 3.91926265 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.55218946 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.52774427 |
| 9 | Optic neuritis (HP:0100653) | 3.52774427 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.48360117 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.47431398 |
| 12 | Cerebral aneurysm (HP:0004944) | 3.45618891 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42740518 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42740518 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42740518 |
| 16 | T lymphocytopenia (HP:0005403) | 3.21551028 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.20557256 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.18184266 |
| 19 | Meningitis (HP:0001287) | 3.13247838 |
| 20 | Increased IgM level (HP:0003496) | 3.10294632 |
| 21 | Milia (HP:0001056) | 3.08922158 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07978855 |
| 23 | Hand muscle atrophy (HP:0009130) | 3.07954803 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.01017520 |
| 25 | Recurrent skin infections (HP:0001581) | 3.00042592 |
| 26 | Abnormality of T cell number (HP:0011839) | 2.92660780 |
| 27 | Vasculitis (HP:0002633) | 2.92165653 |
| 28 | Aortic aneurysm (HP:0004942) | 2.91432197 |
| 29 | Encephalitis (HP:0002383) | 2.90992503 |
| 30 | Obstructive lung disease (HP:0006536) | 2.89049369 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89049369 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88473336 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 2.87170431 |
| 34 | Distal upper limb amyotrophy (HP:0007149) | 2.83443950 |
| 35 | Upper limb amyotrophy (HP:0009129) | 2.83443950 |
| 36 | Atrophic scars (HP:0001075) | 2.83073306 |
| 37 | Cervical subluxation (HP:0003308) | 2.82923680 |
| 38 | Recurrent viral infections (HP:0004429) | 2.82484083 |
| 39 | Ankle contracture (HP:0006466) | 2.82255871 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.82215781 |
| 41 | Pili torti (HP:0003777) | 2.80897847 |
| 42 | Selective tooth agenesis (HP:0001592) | 2.77739907 |
| 43 | Increased IgE level (HP:0003212) | 2.77122055 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 2.74288854 |
| 45 | Loss of speech (HP:0002371) | 2.70611842 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.69379075 |
| 47 | Cellulitis (HP:0100658) | 2.67974713 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65840791 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65840791 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.63845550 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.61391171 |
| 52 | Nasal polyposis (HP:0100582) | 2.58287017 |
| 53 | Urticaria (HP:0001025) | 2.58230638 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.58026034 |
| 55 | Abnormality of T cells (HP:0002843) | 2.56878618 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.54555071 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.52612613 |
| 58 | Gingivitis (HP:0000230) | 2.52302756 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.49784907 |
| 60 | Agammaglobulinemia (HP:0004432) | 2.48671954 |
| 61 | Peritonitis (HP:0002586) | 2.47711661 |
| 62 | Dilatation of the ascending aorta (HP:0005111) | 2.47162732 |
| 63 | Granulocytopenia (HP:0001913) | 2.44907195 |
| 64 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.44676885 |
| 65 | Keratoconjunctivitis (HP:0001096) | 2.44162700 |
| 66 | Leukocytosis (HP:0001974) | 2.43341431 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42781515 |
| 68 | Right ventricular cardiomyopathy (HP:0011663) | 2.41074950 |
| 69 | Petechiae (HP:0000967) | 2.40324035 |
| 70 | Slow saccadic eye movements (HP:0000514) | 2.37460806 |
| 71 | Lymphopenia (HP:0001888) | 2.35965375 |
| 72 | Chest pain (HP:0100749) | 2.33817665 |
| 73 | Premature rupture of membranes (HP:0001788) | 2.33612987 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.31848091 |
| 75 | Plantar hyperkeratosis (HP:0007556) | 2.31005318 |
| 76 | Colitis (HP:0002583) | 2.30098963 |
| 77 | Onycholysis (HP:0001806) | 2.30057817 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.28468579 |
| 79 | Polycythemia (HP:0001901) | 2.27294334 |
| 80 | Fragile nails (HP:0001808) | 2.25894090 |
| 81 | Eczematoid dermatitis (HP:0000976) | 2.24626045 |
| 82 | Nail dystrophy (HP:0008404) | 2.24160099 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.24113467 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23993512 |
| 85 | Aortic dissection (HP:0002647) | 2.23986265 |
| 86 | Purpura (HP:0000979) | 2.21875330 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.21700748 |
| 88 | Hemoptysis (HP:0002105) | 2.21266851 |
| 89 | Verrucae (HP:0200043) | 2.18689778 |
| 90 | Papilloma (HP:0012740) | 2.18689778 |
| 91 | J-shaped sella turcica (HP:0002680) | 2.18245817 |
| 92 | Xanthomatosis (HP:0000991) | 2.17805599 |
| 93 | Mitral valve prolapse (HP:0001634) | 2.17240649 |
| 94 | Myocardial infarction (HP:0001658) | 2.17055063 |
| 95 | Hematochezia (HP:0002573) | 2.16384434 |
| 96 | Sepsis (HP:0100806) | 2.16365185 |
| 97 | Joint swelling (HP:0001386) | 2.14716413 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.14333614 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13361352 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.13213196 |
| 101 | Eosinophilia (HP:0001880) | 2.12065129 |
| 102 | Radial bowing (HP:0002986) | 2.10240625 |
| 103 | IgG deficiency (HP:0004315) | 2.09831968 |
| 104 | Acute hepatic failure (HP:0006554) | 2.09506895 |
| 105 | Genu recurvatum (HP:0002816) | 2.09468107 |
| 106 | Episodic fever (HP:0001954) | 2.09043641 |
| 107 | Epistaxis (HP:0000421) | 2.07091792 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 2.06755824 |
| 109 | Mesangial abnormality (HP:0001966) | 2.06156765 |
| 110 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05987104 |
| 111 | Aneurysm (HP:0002617) | 2.04251065 |
| 112 | Increased serum ferritin (HP:0003281) | 2.02848551 |
| 113 | Anorexia (HP:0002039) | 2.02822696 |
| 114 | Abnormal hair laboratory examination (HP:0003328) | 2.02672408 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 2.01952956 |
| 116 | Hydroxyprolinuria (HP:0003080) | 2.01464587 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 2.01464587 |
| 118 | Shallow orbits (HP:0000586) | 2.01176411 |
| 119 | Achilles tendon contracture (HP:0001771) | 2.00256008 |
| 120 | Abnormality of eosinophils (HP:0001879) | 1.98731761 |
| 121 | Amyloidosis (HP:0011034) | 1.97384688 |
| 122 | Severe combined immunodeficiency (HP:0004430) | 1.96006461 |
| 123 | Metaphyseal cupping (HP:0003021) | 1.95201385 |
| 124 | Esophageal varix (HP:0002040) | 1.95131384 |
| 125 | Gingival bleeding (HP:0000225) | 1.94851271 |
| 126 | Woolly hair (HP:0002224) | 1.94730003 |
| 127 | Growth hormone excess (HP:0000845) | 1.94400475 |
| 128 | Gangrene (HP:0100758) | 1.93801931 |
| 129 | Recurrent bronchitis (HP:0002837) | 1.93262341 |
| 130 | Wrist flexion contracture (HP:0001239) | 1.89341384 |
| 131 | Osteomyelitis (HP:0002754) | 1.88591801 |
| 132 | Acne (HP:0001061) | 1.88578010 |
| 133 | Thin bony cortex (HP:0002753) | 1.86754381 |
| 134 | Palmoplantar hyperkeratosis (HP:0000972) | 1.85823374 |
| 135 | Prolonged neonatal jaundice (HP:0006579) | 1.85697251 |
| 136 | Joint stiffness (HP:0001387) | 1.84858965 |
| 137 | Chronic otitis media (HP:0000389) | 1.84306958 |
| 138 | Abnormality of nail color (HP:0100643) | 1.84220356 |
| 139 | Back pain (HP:0003418) | 1.82530552 |
| 140 | Bowing of the arm (HP:0006488) | 1.82041089 |
| 141 | Bowed forearm bones (HP:0003956) | 1.82041089 |
| 142 | Easy fatigability (HP:0003388) | 1.81904408 |
| 143 | Progressive neurologic deterioration (HP:0002344) | 1.81528294 |
| 144 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81193825 |
| 145 | Mucopolysacchariduria (HP:0008155) | 1.81193825 |
| 146 | Malnutrition (HP:0004395) | 1.80753577 |
| 147 | Spastic diplegia (HP:0001264) | 1.80474241 |
| 148 | Thrombocytosis (HP:0001894) | 1.79707032 |
| 149 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79110566 |
| 150 | Osteolytic defects of the hand bones (HP:0009699) | 1.79110566 |
| 151 | Hypotrichosis (HP:0001006) | 1.77983152 |
| 152 | Camptodactyly of toe (HP:0001836) | 1.77747896 |
| 153 | Deep venous thrombosis (HP:0002625) | 1.77599407 |
| 154 | Autoimmune thrombocytopenia (HP:0001973) | 1.77582163 |
| 155 | Emphysema (HP:0002097) | 1.77491456 |
| 156 | Alopecia of scalp (HP:0002293) | 1.76430128 |
| 157 | Ulnar bowing (HP:0003031) | 1.75737457 |
| 158 | Blue sclerae (HP:0000592) | 1.73823981 |
| 159 | Ulnar deviation of the wrist (HP:0003049) | 1.73536252 |
| 160 | Polygenic inheritance (HP:0010982) | 1.72995211 |
| 161 | Ectopia lentis (HP:0001083) | 1.71428400 |
| 162 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.69172662 |
| 163 | Flat acetabular roof (HP:0003180) | 1.67656005 |
| 164 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.67527028 |
| 165 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.67527028 |
| 166 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.67527028 |
| 167 | Increased density of long bones (HP:0006392) | 1.67300385 |
| 168 | Long toe (HP:0010511) | 1.67064456 |
| 169 | Biconcave vertebral bodies (HP:0004586) | 1.65890577 |
| 170 | Palmar hyperkeratosis (HP:0010765) | 1.64772787 |
| 171 | Increased connective tissue (HP:0009025) | 1.63322212 |
| 172 | Fatigue (HP:0012378) | 1.62713124 |
| 173 | Trismus (HP:0000211) | 1.62470084 |
| 174 | Mitral stenosis (HP:0001718) | 1.62419742 |
| 175 | Chondrocalcinosis (HP:0000934) | 1.62396634 |
| 176 | Difficulty climbing stairs (HP:0003551) | 1.62023201 |
| 177 | Broad metatarsal (HP:0001783) | 1.60714472 |
| 178 | Abnormal cartilage morphology (HP:0002763) | 1.59908548 |
| 179 | Distal lower limb muscle weakness (HP:0009053) | 1.59621956 |
| 180 | Skin ulcer (HP:0200042) | 1.59532299 |
| 181 | Pustule (HP:0200039) | 1.59437654 |
| 182 | Elbow flexion contracture (HP:0002987) | 1.59037488 |
| 183 | Spinal muscular atrophy (HP:0007269) | 1.54957182 |
| 184 | Persistence of primary teeth (HP:0006335) | 1.54395859 |
| 185 | Stroke (HP:0001297) | 1.53777259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.34848884 |
| 2 | ERN1 | 3.27773801 |
| 3 | EEF2K | 2.83162618 |
| 4 | PRPF4B | 2.77240199 |
| 5 | PKN2 | 2.73924641 |
| 6 | MAP3K10 | 2.68756541 |
| 7 | RIPK4 | 2.61019463 |
| 8 | MAPKAPK3 | 2.49599674 |
| 9 | EPHA2 | 2.47492914 |
| 10 | FGFR4 | 2.24543538 |
| 11 | TGFBR2 | 2.24155423 |
| 12 | MAP4K1 | 2.13035284 |
| 13 | LRRK2 | 2.08279807 |
| 14 | TNK2 | 2.00716930 |
| 15 | SIK3 | 1.99407310 |
| 16 | MAP3K3 | 1.94946951 |
| 17 | TXK | 1.86973197 |
| 18 | STK10 | 1.84097206 |
| 19 | FES | 1.83838761 |
| 20 | TYK2 | 1.83738572 |
| 21 | TBK1 | 1.81352818 |
| 22 | JAK3 | 1.78766428 |
| 23 | SCYL2 | 1.74007807 |
| 24 | PTK6 | 1.68614097 |
| 25 | RIPK1 | 1.63596076 |
| 26 | MAP3K13 | 1.62965397 |
| 27 | IRAK4 | 1.59674222 |
| 28 | TTN | 1.58107201 |
| 29 | SIK1 | 1.55814227 |
| 30 | ZAP70 | 1.52050952 |
| 31 | IRAK3 | 1.48431727 |
| 32 | RPS6KB2 | 1.43799577 |
| 33 | GRK6 | 1.43522252 |
| 34 | TGFBR1 | 1.41780648 |
| 35 | TESK1 | 1.34323012 |
| 36 | KDR | 1.31421784 |
| 37 | PAK4 | 1.30539223 |
| 38 | TAOK1 | 1.30433695 |
| 39 | NME2 | 1.27438767 |
| 40 | PRKD2 | 1.27073032 |
| 41 | RPS6KA4 | 1.26941799 |
| 42 | TAOK3 | 1.25679116 |
| 43 | FLT3 | 1.25027014 |
| 44 | SMG1 | 1.24899654 |
| 45 | MAP2K3 | 1.24705451 |
| 46 | MAP3K14 | 1.23361594 |
| 47 | BCKDK | 1.22388570 |
| 48 | TESK2 | 1.21487142 |
| 49 | SYK | 1.17708702 |
| 50 | DDR2 | 1.09172947 |
| 51 | PIM2 | 1.08574929 |
| 52 | CDC42BPA | 1.08243148 |
| 53 | KSR2 | 1.05571289 |
| 54 | EPHA3 | 1.05567839 |
| 55 | CHUK | 1.04330253 |
| 56 | MAP3K11 | 1.01571443 |
| 57 | MARK2 | 1.01441535 |
| 58 | PTK2 | 1.01333315 |
| 59 | IKBKB | 0.98254111 |
| 60 | MAP3K9 | 0.97867012 |
| 61 | LYN | 0.96180031 |
| 62 | PDGFRA | 0.94976230 |
| 63 | NEK2 | 0.93498165 |
| 64 | EPHB1 | 0.93297833 |
| 65 | MAP3K8 | 0.92883910 |
| 66 | JAK1 | 0.91033722 |
| 67 | MAPK15 | 0.89422987 |
| 68 | FGR | 0.87184926 |
| 69 | MATK | 0.85403867 |
| 70 | IKBKE | 0.84059297 |
| 71 | KIT | 0.83262079 |
| 72 | CDK4 | 0.81852121 |
| 73 | MAP3K6 | 0.79793045 |
| 74 | ITK | 0.77408258 |
| 75 | MAP2K2 | 0.76740409 |
| 76 | FGFR3 | 0.76456988 |
| 77 | PRKD3 | 0.75690235 |
| 78 | MTOR | 0.75227454 |
| 79 | CSK | 0.72664349 |
| 80 | ICK | 0.71835526 |
| 81 | MAPK7 | 0.70689904 |
| 82 | HIPK2 | 0.70509592 |
| 83 | CDK6 | 0.69658692 |
| 84 | STK38 | 0.68583931 |
| 85 | NLK | 0.68279056 |
| 86 | ARAF | 0.67817794 |
| 87 | MAPK12 | 0.67636559 |
| 88 | BTK | 0.67489789 |
| 89 | TSSK6 | 0.67156167 |
| 90 | PDK1 | 0.65667993 |
| 91 | JAK2 | 0.65480843 |
| 92 | PIM1 | 0.65461381 |
| 93 | BMX | 0.63220308 |
| 94 | GRK7 | 0.63198736 |
| 95 | PAK2 | 0.62662186 |
| 96 | MST1R | 0.62272013 |
| 97 | PDPK1 | 0.62064590 |
| 98 | RPS6KC1 | 0.61863453 |
| 99 | RPS6KL1 | 0.61863453 |
| 100 | PRKCQ | 0.61733302 |
| 101 | NEK1 | 0.61586475 |
| 102 | CSF1R | 0.61360705 |
| 103 | RPS6KA2 | 0.60984038 |
| 104 | CDK12 | 0.59939242 |
| 105 | BUB1 | 0.58334976 |
| 106 | DYRK1B | 0.58175594 |
| 107 | MAP3K2 | 0.57429260 |
| 108 | MUSK | 0.56919473 |
| 109 | MARK3 | 0.55703108 |
| 110 | LATS2 | 0.55156486 |
| 111 | PASK | 0.54053072 |
| 112 | CAMKK1 | 0.53749848 |
| 113 | HCK | 0.53502484 |
| 114 | RPS6KA6 | 0.52391073 |
| 115 | FER | 0.51957605 |
| 116 | MET | 0.51878158 |
| 117 | MAPK11 | 0.50909531 |
| 118 | MAP3K5 | 0.49938295 |
| 119 | MAP2K1 | 0.49535242 |
| 120 | ACVR1B | 0.48955795 |
| 121 | ALK | 0.48642992 |
| 122 | MAP3K1 | 0.48194368 |
| 123 | BLK | 0.47538244 |
| 124 | MAP3K7 | 0.47497357 |
| 125 | FGFR1 | 0.46933986 |
| 126 | MOS | 0.45618413 |
| 127 | PRKCI | 0.44699630 |
| 128 | RET | 0.44053261 |
| 129 | NTRK1 | 0.43899540 |
| 130 | TAOK2 | 0.41137306 |
| 131 | MAPKAPK2 | 0.40927576 |
| 132 | RAF1 | 0.40808565 |
| 133 | IRAK1 | 0.40362496 |
| 134 | SIK2 | 0.39754769 |
| 135 | FYN | 0.39733962 |
| 136 | MST4 | 0.39120855 |
| 137 | LCK | 0.37629318 |
| 138 | TEC | 0.37373571 |
| 139 | MAP2K6 | 0.36987224 |
| 140 | MAPK4 | 0.36198721 |
| 141 | PRKD1 | 0.33120619 |
| 142 | CAMKK2 | 0.33027343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.48788162 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.39934890 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.28932363 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09289599 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08085926 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.98669029 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77954851 |
| 8 | Malaria_Homo sapiens_hsa05144 | 1.69947048 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68480934 |
| 10 | Bladder cancer_Homo sapiens_hsa05219 | 1.66381089 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.62843861 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56079197 |
| 13 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.53785435 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53254725 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50839215 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.48321709 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47636498 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46081523 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45882360 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.44333796 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38066956 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37477230 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33961760 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.29740937 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29604343 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.28939728 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28441833 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27134661 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27127748 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26111790 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26084344 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23574710 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23200643 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20048915 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19352509 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17157472 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14181114 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13397753 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.12621953 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11509159 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10189436 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.09819018 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06978723 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.06843227 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05039970 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04862688 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03456618 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02912770 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01249047 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00710527 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00077361 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.99591921 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 0.98710523 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97742665 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96868922 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.96655959 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95508595 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.94897635 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94620579 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94570517 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94331604 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.92921054 |
| 63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92811355 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.92035576 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.91700781 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91251534 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.89749701 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87389016 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87206392 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85788500 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85752605 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85621992 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.84108388 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83962408 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83893767 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82941625 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81367562 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80069140 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79668410 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79563574 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.79298331 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78716611 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78697322 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.78026886 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77722458 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77500279 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76585827 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75485304 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.74282574 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73734324 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73147268 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72559603 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72509686 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72443446 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71610742 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71289878 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71239585 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71078514 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70849050 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70180339 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68927799 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66753671 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66558516 |
| 104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63869982 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63812907 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63359334 |
| 107 | DNA replication_Homo sapiens_hsa03030 | 0.62842684 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62362206 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62217569 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.61946994 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61754647 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61534423 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61404643 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60916402 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.60629983 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60529767 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60410009 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59709378 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59009144 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.58324176 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58275165 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58043001 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56683978 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55196490 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55024935 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54926519 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.54566713 |
| 128 | Base excision repair_Homo sapiens_hsa03410 | 0.54026437 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52293670 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51059584 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50420459 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49483552 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49447409 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47524438 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45506477 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43891149 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41363412 |
| 138 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37086068 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33572888 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32894577 |

